molecular diagnostics

When you are sick, the old way to find out why was to look — at your skin, your X-ray, a stained slide of your cells under a microscope. Molecular diagnostics asks a more precise question: what do the actual molecules say? It reads your DNA, RNA, or proteins directly, looking for the specific molecular signature of a disease or a microbe.

Most molecular tests work by recognition and amplification — finding a tiny target sequence and copying it until it can be seen. A test for a virus, for instance, uses short DNA primers designed to match a unique stretch of the virus's genome; if that sequence is present, a reaction called PCR copies it billions of times and a signal lights up. The same logic detects a disease-causing mutation in a patient's gene, identifies which bacterium is causing an infection (and which antibiotics it resists), or finds the genetic markers used in carrier screening before pregnancy. Because the test reads sequence, it can be exquisitely specific: it can tell a harmless variant from a dangerous one, or one strain of flu from another.

Molecular diagnostics is now the backbone of modern testing — the COVID-19 PCR test most of the world took is a molecular diagnostic. Its great strength, sensitivity, is also its great danger: because PCR copies any matching DNA, a single stray molecule of contamination can give a false positive, which is why these tests demand scrupulous lab discipline and proper controls. And a positive result tells you a sequence is present, not necessarily that it is causing the illness — finding a virus's genome is not the same as proving it is the reason a patient is sick.